ACTRN12618001362280已完成2 期
A double-blind, randomized, placebo-controlled, 4-way crossover trial investigating the effect of a soluble fibre supplement on asthma control and airway inflammation in stable asthma.
niversity of Newcastle0 个研究点目标入组 40 人开始时间: 2018年8月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Males and females aged 18 years and over.
- •Doctor diagnosis of asthma and confirmed airway hyper-responsiveness
- •Poorly controlled asthma, defined as ACQ6 >0.75 units
排除标准
- •Recent (past month) respiratory tract infection; respiratory conditions other than asthma; non-adherence to prescribed asthma medications; dietary modifications unsuitable; current diagnosis of diabetes or active gastrointestinal disease; recent antibiotic or laxative use; nutritional, fibre or probiotic supplement use (this includes any vitamin or minerals, sports supplements, meal replacements, probiotics and fibre preparations) within the previous 4 weeks; current smokers; pregnancy or breastfeeding; chronic or excessive alcohol consumption; unexplained weight loss (>5% body weight) in the past 6 months; current use of anti-inflammatory medications (e.g. corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDS)); terminal illness; galactosemia or ragweed allergy.
研究者
相似试验
已完成
不适用
A randomized, double-blind, placebo-controlled, 4-period, two part cross-over study to evaluate the potential interaction effect between 4 mg/kg and 16 mg/kg sugammadex and enoxaparin or unfractionated heparin on anticoagulation activity in young healthy male volunteerscoagulationthrombus10014523NL-OMON36201Schering-Plough80
进行中（未招募）
不适用
A randomized, double-blind, placebo-controlled, 4-way crossover study of ITI-007 in subjects with sleep maintenance insomniaSleep maintenance disordersMedDRA version: 9.1Level: LLTClassification code 10040984Term: Sleep disorderEUCTR2007-004640-78-FRIntra-Cellular Therapies, Inc
已完成
不适用
A randomized, double-blind, placebo-controlled, 4-period cross-over drug-drug interaction study to evaluate the effect of sugammadex and aspirin on platelet aggregation and coagulation parameters in young healthy male volunteerscoagulationplatelet aggregation1003553410014523NL-OMON34161Schering-Plough36
进行中（未招募）
不适用
A double-blind, randomised, placebo-controlled, 4-way cross-over Phase I study to investigate the pharmacokinetics, pharmacodynamics and safety of escalating single doses of E-52862 in young healthy male and female subjectsPainMedDRA version: 12.1Level: LLTClassification code 10033371Term: PainEUCTR2010-020343-13-GBaboratorios del Dr Esteve S.A
进行中（未招募）
1 期
The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE)Post Partum Hypertension after preeclamptic pregnancyEUCTR2014-002524-27-NLniversity Medical Center Utrecht